Literature DB >> 626124

Progressive nature of myocardial injury in selected patients with cardiogenic shock.

A L Gutovitz, B E Sobel, R Roberts.   

Abstract

To determine whether the extensive myocardial injury associated with cardiogenic shock in some patients results from a progressive rather than a discrete massive insult, a study was made of 15 selected patients who had cardiogenic shock within 48 hours of admission, 5 patients with hypovolemic shock without myocardial infarction and 11 patients with myocardial infarction without shock. Peak plasma MB creatine kinase (CK) activity was significantly higher in the seven patients with cardiogenic shock associated with initial infarction (213 international units [IU]/liter) than in patients with shock and previous infarction (98 IU/liter) and in patients with uncomplicated myocardial infarction (125 IU/liter). A prolonged time to peak MB CK activity (averaging 26 hours) and a plateau of elevated MB CK activity were seen in patients with shock associated with initial infarction. Because shock itself did not slow the rate of apparent MB CK disappearance, results obtained suggest that cardiogenic shock associated with initial infarction in selected patients results from progressive myocardial damage underlying continuing release of MB CK into the circulation. The findings are compatible with the concept that, in these patients, cardiogenic shock reflects a vicious cycle of spreading myocardial injury, progressive compromise of cardiac function, exacerbation of ischemia and perpetuation of myocardial damage.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 626124     DOI: 10.1016/0002-9149(78)90001-2

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  8 in total

1.  Thrombolysis in Acute Myocardial Infarction Complicated by Cardiogenic Shock.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

2.  Measurement of cardiac reserve in cardiogenic shock: implications for prognosis and management.

Authors:  L B Tan; W A Littler
Journal:  Br Heart J       Date:  1990-08

Review 3.  Cardiogenic shock: therapy and prevention.

Authors:  W L Barry; I J Sarembock
Journal:  Clin Cardiol       Date:  1998-02       Impact factor: 2.882

4.  Acute myocardial infarction with cardiogenic shock on admission: incidence, prognostic implications, and current treatment strategies. Results from "the 60-Minutes Myocardial Infarction Project". ALKK ("Arbeitsgemeinschaft leitender Krankenhauskardiologen") Study Group.

Authors:  W Beermann; J Carlsson; J Rustige; R Schiele; J Senges; U Tebbe
Journal:  Herz       Date:  1999-08       Impact factor: 1.443

5.  Early recovery of regional performance in salvaged ischemic myocardium following coronary artery occlusion in the dog.

Authors:  J R Darsee; R A Kloner; E Braunwald
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

6.  Functional characterization of left ventricular segmental responses during the initial 24 h and 1 wk after experimental canine myocardial infarction.

Authors:  P Roan; F Scales; S Saffer; L M Buja; J T Willerson
Journal:  J Clin Invest       Date:  1979-10       Impact factor: 14.808

7.  PRediction of infarct size by enzymatic techniques: modification of a method and clinical application.

Authors:  G Tommasini; M Presta
Journal:  Br Heart J       Date:  1979-09

8.  The effect of Allium sativum on ischemic preconditioning and ischemia reperfusion induced cardiac injury.

Authors:  Rajbir Bhatti; Kushlinder Singh; M P S Ishar; Jatinder Singh
Journal:  Indian J Pharmacol       Date:  2008-11       Impact factor: 1.200

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.